183 related articles for article (PubMed ID: 19030935)
1. Combination therapy with histone deacetylase inhibitors and lithium chloride: a novel treatment for carcinoid tumors.
Adler JT; Hottinger DG; Kunnimalaiyaan M; Chen H
Ann Surg Oncol; 2009 Feb; 16(2):481-6. PubMed ID: 19030935
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of growth in medullary thyroid cancer cells with histone deacetylase inhibitors and lithium chloride.
Adler JT; Hottinger DG; Kunnimalaiyaan M; Chen H
J Surg Res; 2010 Apr; 159(2):640-4. PubMed ID: 19394967
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitors upregulate Notch-1 and inhibit growth in pheochromocytoma cells.
Adler JT; Hottinger DG; Kunnimalaiyaan M; Chen H
Surgery; 2008 Dec; 144(6):956-61; discussion 961-2. PubMed ID: 19041003
[TBL] [Abstract][Full Text] [Related]
4. Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells.
Greenblatt DY; Vaccaro AM; Jaskula-Sztul R; Ning L; Haymart M; Kunnimalaiyaan M; Chen H
Oncologist; 2007 Aug; 12(8):942-51. PubMed ID: 17766653
[TBL] [Abstract][Full Text] [Related]
5. Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition.
Leng Y; Liang MH; Ren M; Marinova Z; Leeds P; Chuang DM
J Neurosci; 2008 Mar; 28(10):2576-88. PubMed ID: 18322101
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells.
Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
Mol Cancer Ther; 2007 Mar; 6(3):1151-8. PubMed ID: 17363508
[TBL] [Abstract][Full Text] [Related]
7. Suberoyl bishydroxamic acid inhibits cellular proliferation by inducing cell cycle arrest in carcinoid cancer cells.
Greenblatt DY; Cayo M; Ning L; Jaskula-Sztul R; Haymart M; Kunnimalaiyaan M; Chen H
J Gastrointest Surg; 2007 Nov; 11(11):1515-20; discussion 1520. PubMed ID: 17874277
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells.
Baradari V; Huether A; Höpfner M; Schuppan D; Scherübl H
Endocr Relat Cancer; 2006 Dec; 13(4):1237-50. PubMed ID: 17158768
[TBL] [Abstract][Full Text] [Related]
9. MG-132 inhibits carcinoid growth and alters the neuroendocrine phenotype.
Chen JY; Cook MR; Pinchot SN; Kunnimalaiyaan M; Chen H
J Surg Res; 2010 Jan; 158(1):15-9. PubMed ID: 19765735
[TBL] [Abstract][Full Text] [Related]
10. Notch1 mediates growth suppression of papillary and follicular thyroid cancer cells by histone deacetylase inhibitors.
Xiao X; Ning L; Chen H
Mol Cancer Ther; 2009 Feb; 8(2):350-6. PubMed ID: 19190121
[TBL] [Abstract][Full Text] [Related]
11. Valproic acid induces Notch1 signaling in small cell lung cancer cells.
Platta CS; Greenblatt DY; Kunnimalaiyaan M; Chen H
J Surg Res; 2008 Jul; 148(1):31-7. PubMed ID: 18570928
[TBL] [Abstract][Full Text] [Related]
12. Valproate recovers the inhibitory effect of dexamethasone on the proliferation of the adult dentate gyrus-derived neural precursor cells via GSK-3β and β-catenin pathway.
Boku S; Nakagawa S; Masuda T; Nishikawa H; Kato A; Takamura N; Omiya Y; Kitaichi Y; Inoue T; Kusumi I
Eur J Pharmacol; 2014 Jan; 723():425-30. PubMed ID: 24211784
[TBL] [Abstract][Full Text] [Related]
13. The mood stabilizer valproate activates human FGF1 gene promoter through inhibiting HDAC and GSK-3 activities.
Kao CY; Hsu YC; Liu JW; Lee DC; Chung YF; Chiu IM
J Neurochem; 2013 Jul; 126(1):4-18. PubMed ID: 23647222
[TBL] [Abstract][Full Text] [Related]
14. Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons.
Hall AC; Brennan A; Goold RG; Cleverley K; Lucas FR; Gordon-Weeks PR; Salinas PC
Mol Cell Neurosci; 2002 Jun; 20(2):257-70. PubMed ID: 12093158
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of protein L-isoaspartyl methyltransferase expression by lithium is mediated by glycogen synthase kinase-3 inactivation and beta-catenin stabilization.
Lamarre M; Desrosiers RR
Neuropharmacology; 2008 Oct; 55(5):669-76. PubMed ID: 18582478
[TBL] [Abstract][Full Text] [Related]
16. Lithium inhibits proliferation of human esophageal cancer cell line Eca-109 by inducing a G2/M cell cycle arrest.
Wang JS; Wang CL; Wen JF; Wang YJ; Hu YB; Ren HZ
World J Gastroenterol; 2008 Jul; 14(25):3982-9. PubMed ID: 18609681
[TBL] [Abstract][Full Text] [Related]
17. Adenomatous polyposis coli determines sensitivity to histone deacetylase inhibitor-induced apoptosis in colon cancer cells.
Huang X; Guo B
Cancer Res; 2006 Sep; 66(18):9245-51. PubMed ID: 16982769
[TBL] [Abstract][Full Text] [Related]
18. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons.
Yasuda S; Liang MH; Marinova Z; Yahyavi A; Chuang DM
Mol Psychiatry; 2009 Jan; 14(1):51-9. PubMed ID: 17925795
[TBL] [Abstract][Full Text] [Related]
19. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.
Fedier A; Dedes KJ; Imesch P; Von Bueren AO; Fink D
Int J Oncol; 2007 Sep; 31(3):633-41. PubMed ID: 17671692
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effects of GSK-3β and HDAC inhibitors in intracerebroventricular streptozotocin-induced cognitive deficits in rats.
Sharma S; Taliyan R
Naunyn Schmiedebergs Arch Pharmacol; 2015 Mar; 388(3):337-49. PubMed ID: 25547373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
